What is Providence Therapeutics's contact information?

Providence Therapeutics's contact information: 4034403599, +14034403599.

How many employees does Providence Therapeutics have?

Providence Therapeutics has 58 employees.

What industry does Providence Therapeutics belong to?

Providence Therapeutics is in the industry of: Research, Pharmaceuticals, Biotechnology, Healthcare, Biotechnology Research.

What are Providence Therapeutics's official social media profiles?

Providence Therapeutics Linkedin Page

What tech stack does Providence Therapeutics use?

Some of the popular technologies that Providence Therapeutics uses are: Google Analytics, Google Hosted Libraries, jsDelivr, Bunny, Joomla.

What are Providence Therapeutics's office addresses?

Providence Therapeutics has 2 known office addresses: 120 - 8832 Blackfoot Trail S.E., Calgary, AB T2J 3J1 120, 8832 Blackfoot Trail Calgary, Alberta T2J 3J1, CA.

What is Providence Therapeutics's estimated annual revenue?

Providence Therapeutics's revenue is $10,000,000

What is Providence Therapeutics's open headcount?

Providence Therapeutics has no job postings yet.

What is the number of ad campaigns for Providence Therapeutics?

Providence Therapeutics has no advertisements yet.

What is the number of recent news articles about Providence Therapeutics?

Providence Therapeutics has 2 news articles.

Providence Therapeutics - Pubrio Company Profile & Intent

Providence Therapeutics

Canada · Biotechnology Research

Research

Pharmaceuticals

Biotechnology

Healthcare

Biotechnology Research

Providence Therapeutics Holdings Inc is a clinical-stage biotechnology company focused on drug development and platform development. The Providence mRNA Medicines platform is comprised of three integrated platforms: 1) mRNA Medicines Platform, 2) INTENT™ Lipid Nanoparticle Platform (LNP), and 3) Manufacturing Platform. Providence’s mRNA and INTENT™ LNP platform offer an end-to-end solution for designing codon-optimized ultrapure mRNA that can be formulated in application optimized LNP. The Providence proprietary INTENT™ LNP platform, consists of rationally designed lipids that have been tested for suitability for programs in oncology, infectious diseases and gene delivery. Our scalable, efficient platform demonstrates differentiated capabilities in mRNA design, manufacturing, and formulation processes, as well as specific organ and tissue targeting. For more information, please visit providencetherapeutics.com